Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05493982 · ClinicalTrials.gov registry record · NA
Evaluation of the Be Vape Free Curriculum of the Tobacco Prevention Toolkit
A NA study, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 2,779
- Enrollment target
NCT05493982: Completed NA study, sponsored by Stanford University.
NCT05493982 is a NA study that has completed, run by Stanford University. The registered enrollment target is 2,779 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05493982, a NA study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 2,779 participants
- Enrollment target
Study Summary
The Stanford Tobacco Prevention Toolkit is a free online curriculum developed for use by educators and health professionals in providing tobacco-specific prevention education to middle and high school students. A set of lessons focused on e-cigarette/vaping prevention education specifically is called the Be Vape Free curriculum. The aims of this study are to determine: (1) whether the Be Vape Free curriculum is effective in increasing middle and high school students' resistance to using tobacco and in decreasing positive attitudes towards and intentions to use e-cigarettes; (2) whether the Curriculum is effective in changing middle and high school students' actual use of tobacco; and (3) Examine heterogenous treatment effects identifying groups that benefit the most and those who do not benefit at all from the intervention.
Primary Outcome
Investigator-originated survey measures (questions) assess ever e-cigarette use \& past 30-day tobacco use. This outcome measure assesses e-cigarette use.
Interventions
- BEHAVIORAL Stanford Vaping Prevention curriculum
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,779 participants |
| Start Date | 2022-10-19 |
| Est. Completion | 2026-05-08 |
| Phase | NA |
What the finished NCT05493982 record still lists
NCT05493982 is an interventional study that assigns participants to a tested intervention. Its 2,779 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% higher).
The record links to 0 conditions, and to 1 intervention - of which Stanford Vaping Prevention curriculum is the first listed.
NCT05493982 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05493982 about?
NCT05493982 is a clinical study titled "Evaluation of the Be Vape Free Curriculum of the Tobacco Prevention Toolkit". The Stanford Tobacco Prevention Toolkit is a free online curriculum developed for use by educators and health professionals in providing tobacco-specific prevention education to middle and high school students. A set of lessons focused on e-cigarette/vaping prevention education specifically is calle...
What is the current status of trial NCT05493982?
This trial is currently completed. It is a NA study. The enrollment target is 2,779 participants. The study started on 2022-10-19. Estimated completion is 2026-05-08.
What interventions are being tested in trial NCT05493982?
The interventions under investigation include: Stanford Vaping Prevention curriculum (BEHAVIORAL).
Who is sponsoring clinical trial NCT05493982?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05493982's enrollment target sits among peer trials
2,779 44th of 2000 higher than 1,957 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05443737 · 2,800 participants · Phase 3
Evaluation of a Telehealth Oncofertility Care Intervention in Adolescent and Young Adult Cancer Patients
- NCT05899439 · 2,800 participants
Immune Function and the Progression to T1D
- NCT06089109 · 2,800 participants · NA
Creating VIP Corps to Reduce Maternal Deaths
- NCT06345339 · 2,800 participants · Phase 2
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI